Ultragenyx Pharmaceutical
RARE
RARE
161 hedge funds and large institutions have $1.81B invested in Ultragenyx Pharmaceutical in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 60 increasing their positions, 59 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
23% less capital invested
Capital invested by funds: $2.35B → $1.81B (-$535M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
161
Holding in Top 10
1
Calls
$5.47M
Puts
$6.35M
Top Buyers
| 1 | +$13.7M | |
| 2 | +$11.9M | |
| 3 | +$8.87M | |
| 4 |
Millennium Management
New York
|
+$8.58M |
| 5 |
Goldman Sachs
New York
|
+$8.01M |
Top Sellers
| 1 | -$33.9M | |
| 2 | -$24.1M | |
| 3 | -$19.1M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$18.6M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$6.58M |